Dr Lalchandani Labs Ltd
DLCLDr Lalchandani Labs Ltd
DLCL
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹15 cr, stock is ranked 3,685
High RiskStock is 4.66x as volatile as Nifty
28.0020.00% (-7.00)
28.0020.00% (-7.00)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 1.70 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.48 | 5.11 | 0.70% |
Forecast & Ratings
Detailed Forecast—
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Dr Lalchandani Labs is a provider of diagnostic and related healthcare tests and services.
Peers
Compare with peersApollo Hospitals Enterprise Ltd
PE Ratio
95.87
1Y Return
18.09%
Buy Reco %
86.96
Max Healthcare Institute Ltd
PE Ratio
58.90
1Y Return
56.77%
Buy Reco %
60.00
Fortis Healthcare Ltd
PE Ratio
49.44
1Y Return
35.22%
Buy Reco %
100.00
Global Health Ltd
PE Ratio
77.37
1Y Return
99.93%
Buy Reco %
66.67
Narayana Hrudayalaya Ltd
PE Ratio
40.32
1Y Return
54.61%
Buy Reco %
80.00
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4.61 | 2.82 | 5.27 | 6.10 | 9.78 | 11.28 | 5.04 | — | ||||||||
Raw Materials | 3.37 | 0.59 | 0.61 | 1.15 | 3.61 | 2.98 | 1.21 | — | ||||||||
| Power & Fuel Cost | 0.07 | 0.11 | 0.11 | 0.11 | 0.16 | 0.11 | ||||||||||
| Employee Cost | 0.30 | 0.67 | 0.57 | 0.42 | 1.11 | 1.11 | ||||||||||
| Selling & Administrative Expenses | 0.72 | 2.22 | 2.29 | 2.67 | 3.66 | 1.78 | ||||||||||
| Operating & Other expenses | 0.49 | 0.46 | 0.72 | 0.73 | 0.90 | 0.74 | ||||||||||
EBITDA | 1.24 | 0.65 | 1.20 | 1.26 | 2.24 | 2.47 | 0.09 | — | ||||||||
| Depreciation/Amortization | 0.17 | 0.13 | 0.35 | 0.42 | 0.52 | 0.59 | 0.66 | — | ||||||||
| PBIT | 1.07 | 0.52 | 0.85 | 0.84 | 1.72 | 1.88 | -0.57 | — | ||||||||
| Interest & Other Items | 0.36 | 0.16 | 0.14 | 0.18 | 0.35 | 0.60 | 0.99 | — | ||||||||
| PBT | 0.71 | 0.36 | 0.71 | 0.66 | 1.37 | 1.28 | -1.56 | — | ||||||||
| Taxes & Other Items | 0.22 | 0.09 | 0.19 | 0.19 | 0.36 | 0.36 | 0.00 | — | ||||||||
| Net Income | 0.49 | 0.27 | 0.52 | 0.47 | 1.01 | 0.92 | -1.56 | — | ||||||||
| EPS | 5.32 | 0.92 | 1.43 | 1.08 | 2.33 | 2.12 | -3.60 | — | ||||||||
| DPS | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Company Updates
FY 2019
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2022
Annual report
PDFFY 2023
Annual report
PDFPeers & Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Dr Lalchandani Labs Ltd | -9.72 | 1.70 | — |
| Apollo Hospitals Enterprise Ltd | 95.87 | 12.02 | 0.27% |
| Max Healthcare Institute Ltd | 58.90 | 8.77 | 0.15% |
| Fortis Healthcare Ltd | 49.44 | 3.59 | 0.26% |
Price Comparison
Compare DLCL with any stock or ETFCompare DLCL with any stock or ETF
DLCL
Shareholdings
Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Mar 2022
Sep 2022
Mar 2023
Sep 2023
Shareholding History
Foreign Institutions
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
DLCL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Dividends
Hmm, looks like data is unavailable here. Please come back after some time
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 12.31%, vs industry avg of 13.8%
Constant Market Share
Over the last 5 years, market share stayed at 0.01%